Clinical Trial Update: Extension Study of Hetrombopag in Severe Aplastic Anemia [Phase 3]

View source ↗

Summary

Update on a Phase 3 extension study of hetrombopag for treatment-naive severe aplastic anemia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Hetrombopag (hetrombopag)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Treatment-naive Severe Aplastic Anemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING